ECSS
LEGN icon

Eurizon Capital SGR SpA’s Legend Biotech LEGN Stock Holding History

Eurizon Capital SGR SpA’s Portfolio LEGN Stock Details LEGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$279K Sell
9,673
-1,492
-13% -$40.2K ﹤0.01% 700
2026
Q1 		$202K Sell
11,165
-2,451
-18% -$46.7K ﹤0.01% 745
2025
Q4 		$296K Buy
+13,616
New +$390K ﹤0.01% 615

Other funds holding LEGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return

Eurizon Capital SGR SpA's LEGN Position: Q2 2026 in Review

Eurizon Capital SGR SpA reduced its Legend Biotech (LEGN) stake by 13% in Q2 2026, selling an estimated $40.2K and leaving 9,673 shares worth $279K. The position accounts for ﹤0.01% of the portfolio, ranked #700.

Eurizon Capital SGR SpA first reported a position in LEGN in Q4 2025 and has held it in 3 quarters since. The position peaked at $296K in Q4 2025. 219 funds tracked by Wall St. Rank hold LEGN as of Q2 2026.

  • Eurizon Capital SGR SpA held 9,673 shares of Legend Biotech worth $279K as of Q2 2026.
  • Eurizon Capital SGR SpA sold 1,492 Legend Biotech shares in Q2 2026, an estimated $40.2K.
  • Legend Biotech made up ﹤0.01% of Eurizon Capital SGR SpA's portfolio in Q2 2026, its #700 holding.
  • Eurizon Capital SGR SpA first reported a position in Legend Biotech in Q4 2025 and has held it in 3 quarters since.
  • Eurizon Capital SGR SpA's Legend Biotech position peaked at $296K in Q4 2025.
  • 219 funds tracked by Wall St. Rank held Legend Biotech as of Q2 2026.

Based on Eurizon Capital SGR SpA's 13F filing for Q2 2026, filed 29 Jul 2026.